323 related articles for article (PubMed ID: 37795365)
21. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
[TBL] [Abstract][Full Text] [Related]
22. PROTAC therapy as a new targeted therapy for lung cancer.
Li JW; Zheng G; Kaye FJ; Wu L
Mol Ther; 2023 Mar; 31(3):647-656. PubMed ID: 36415148
[TBL] [Abstract][Full Text] [Related]
23. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D
Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992
[TBL] [Abstract][Full Text] [Related]
24. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
Landré V; Rotblat B; Melino S; Bernassola F; Melino G
Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
[TBL] [Abstract][Full Text] [Related]
25. Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach.
VanDyke D; Xu L; Sargunas PR; Gilbreth RN; Baca M; Gao C; Hunt J; Spangler JB
J Biol Chem; 2023 Dec; 299(12):105381. PubMed ID: 37866632
[TBL] [Abstract][Full Text] [Related]
26. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
27. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
28. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases.
Stekel Z; Sheng Y; Zhang W
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883481
[TBL] [Abstract][Full Text] [Related]
29. PROTAC-induced proteolytic targeting.
Carmony KC; Kim KB
Methods Mol Biol; 2012; 832():627-38. PubMed ID: 22350917
[TBL] [Abstract][Full Text] [Related]
30. Targeted protein degradation by PROTACs.
Neklesa TK; Winkler JD; Crews CM
Pharmacol Ther; 2017 Jun; 174():138-144. PubMed ID: 28223226
[TBL] [Abstract][Full Text] [Related]
31. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
[TBL] [Abstract][Full Text] [Related]
32. The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer.
Jin JO; Puranik N; Bui QT; Yadav D; Lee PC
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502538
[TBL] [Abstract][Full Text] [Related]
33. From Discovery to Bedside: Targeting the Ubiquitin System.
Wertz IE; Wang X
Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
[TBL] [Abstract][Full Text] [Related]
34. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
An S; Fu L
EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312
[TBL] [Abstract][Full Text] [Related]
35. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitination and the ubiquitin - proteasome system in the pathogenesis and treatment of squamous head and neck carcinoma.
Voutsadakis IA
Anticancer Res; 2013 Sep; 33(9):3527-41. PubMed ID: 24023278
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Ubiquitin-Proteasome System (UPS) through PROTAC Technology.
Cecchini C; Tardy S; Ceserani V; Theurillat JP; Scapozza L
Chimia (Aarau); 2020 Apr; 74(4):274-277. PubMed ID: 32331546
[TBL] [Abstract][Full Text] [Related]
38. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive profiling of protein ubiquitination for drug discovery.
Xu G; Jaffrey SR
Curr Pharm Des; 2013; 19(18):3315-28. PubMed ID: 23151132
[TBL] [Abstract][Full Text] [Related]
40. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]